PRESSURE BIOSCIENCES (PBIO) earnings
Quarterly and annual PBIO reports and results, each read against the price at its own news timestamp. Back to the PBIO overview →
9 measured PBIO earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q PRESSURE BIOSCIENCES For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Form 10-Q PRESSURE BIOSCIENCES For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form NT 10-Q PRESSURE BIOSCIENCES For: Jun 30 | SEC filing · Form NT | — | — | |
| Form 10-K PRESSURE BIOSCIENCES For: Dec 31 | SEC filing · Form 10-K | -10.21% | -7.08% | |
| Form NT 10-Q PRESSURE BIOSCIENCES For: Mar 31 | SEC filing · Form NT | +0.00% | -0.42% | |
| Form NT 10-K PRESSURE BIOSCIENCES For: Dec 31 | SEC filing · Form NT | +0.00% | +17.65% | |
| Form 10-Q PRESSURE BIOSCIENCES For: Sep 30 | SEC filing · Form 10-Q | -6.05% | -6.05% | |
| Pressure BioSciences, Inc. to Discuss Third Quarter 2023 Financial Results and Provide Business Update | Press release | -8.50% | +0.00% | |
| Form NT 10-Q PRESSURE BIOSCIENCES For: Sep 30 | SEC filing · Form NT | +5.34% | +5.34% |
Keep exploring
More PBIO: analyst actions → · SEC filings → · PBIO overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ASLAN Pharmaceuticals Limited - American Depositary Shares (ASLN) | 67 | -1.96% | 36% |
| IMAGIN MEDICAL INC (IMEXF) | 67 | 0.00% | 25% |
| ABLIVA AB (NEVPF) | 66 | 0.00% | 0% |
| SIRONA BIOCHEM CORP ORD (SRBCF) | 66 | 0.00% | 22% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.